Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2020 Mar 1.

Published in final edited form as: J Cyst Fibros. 2018 Dec 1;18(2):280–285. doi: 10.1016/j.jcf.2018.11.004

Table 2.

Fibroscan measurements (n = 129). Shown are median (IQR) or n (%).

Characteristic		By disease severity
	Overall	No CFLD	CFLD without PHTN	CFLD with PHTN
	(n = 129)	(n = 70)	(n =44)	(n = 15)	P^*
CAP (dB/m), median (IQR)	210 (181,239)	204 (175, 232)	227 (194, 274)	196 (183, 222)	0.02
Steatosis (CAP≥230)	43 (33%)	19 (27%)	21 (48%)	3 (20%)	0.04
LSM (kPa), median (IQR)	53 (4.3, 6.4)	43 (4.2, 5.7)	5.4 (4.5, 65)	113 (6.4, 24.8)	<0.0001

^*

P value from Kruskal-Wallis test or Fisher exact test.